Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

11 Mar 2009 07:00

RNS Number : 6511O
Sopheon PLC
11 March 2009
 



Embargoed Release: 07:00hrs Wednesday 11 March 2009

Sopheon plc

('Sopheon')

Ciba Implements Sopheon's Accolade® Solution to Help Focus Innovation Investments on Most Promising Projects

PLM Software Supports Global Initiative Aimed at Improving Innovation Governance and Increasing Profits and Revenues from New Products

MINNEAPOLIS and LONDON - Mar. 112009 - Sopheon, the international provider of software and services for product lifecycle management (PLM), announced today that Ciba Inc. ('Ciba')leading global manufacturer of specialty chemicalsis implementing Sopheon's Accolade product portfolio and innovation process management solution. Ciba's deployment of the Sopheon system is core to a global initiative aimed at improving returns on innovation investments. The software is being used to enhance the company's capacity to govern its innovation processes and focus resources on high-value product innovation projects.  Accolade has been made available to more than 900 individuals on cross-functional teams responsible for product development at Ciba locations throughout Europe, Asia and the United States. 

Ciba's pedigree as an industry innovator began to develop more than two-and-a-half centuries ago when, in 1758, the company was founded as a trader in chemicals and dyes. In the ensuing years, Ciba has been responsible for scientific breakthroughs in areas ranging from high-performance pigments and antimicrobials, to chemical agents that keep vehicle coatings from peeling after excessive exposure to sunlight. Today the company focuses on the development and production of specialty chemicals, serving customers in more than 120 countries.

In 2006 Ciba set in motion an enterprise-wide effort called Operational Agenda. Its purpose is to strengthen the company's growth and profitability. The program is supported by six strategic pillars, including an initiative dedicated to promoting innovation.  A principal goal of that initiative is to reduce the overall number of projects in the new-product pipeline and ensure that R&D resources are focused on those opportunities that promise high business returns It includes Ciba's implementation of a comprehensive new framework for managing its innovation efforts.

   

Sopheon's Accolade solution will serve as the key software component for Ciba's management of its innovation system. The selection of Accolade was based on a mix of advantages, including the fact that it could be readily configured to Ciba's specific requirements and, once in place, was easy to use. The software's governing capabilities are expected to improve product-development efficiency and quality of execution, by prompting users to follow prescribed process steps and address the right business and technical questions at the right times to optimise the chances of success for projects in the pipeline. Project management will be enhanced by increased transparency as Accolade system managerare able to not only retrieve instant updates on the status of individual projects, but to access consolidated views that allow them to assess the cost, value and priority of projects comprising entire portfolios.

"The introduction of Sopheon's Accolade system accompanied the rejuvenation of Ciba's innovation infrastructure," said Martin Riediker, chief innovation officer for Ciba. "The solution has provided us with a state-of-the-art innovation management system. For the first time, we are able to monitor all aspects of our R&D initiatives and make truly well-informed decisions about which ones to support. As a result, we are in a position to significantly reduce the number of active projects in our development pipeline, and to back the most promising opportunities with more resources. Ultimately, Accolade will also allow us to track and assess the returns on our innovation investments.  It gives us the foundation we need to achieve profitable growth from product innovation well into the future."

Sopheon partners, Sopheon Vertriebs GmbH and Sopheon Business Applications GmbH, were responsible for the sale, implementation and support of Accolade at Ciba.

Dieter Jaeger, chief executive officer of Sopheon Vertriebs GmbH, said, "Innovation has played a critical role throughout Ciba's history. The company's current strategic initiative on innovation is a comprehensive, multi-faceted approach to innovation management. Sopheon's software has been characterised by Ciba as 'the glue that holds it all together.'  With the introduction of Accolade, Ciba is moving the oversight and management of its innovation efforts to a whole new level.

Accolade is a registered trademark of Sopheon plc

-Ends-

For further information:

Barry Mence, Chairman

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Vikki Krause

Hansard Communications

+ 44 (0) 207 245 1100

+ 44 (0) 7957 203 685

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

Paul Davies, 

Corporate Finance

Seymour Pierce

+ 44 (0) 207 107 8000

About Ciba Inc.

Ciba (SWX: CIBN) is a leading global company dedicated to producing high-value effects for its customers' products.  Its products add performance, protection, colour and strength to plastics, paper, automobiles, buildings, home and personal care products and much more. Ciba is active in more than 120 countries around the world and is committed to being a leader in its chosen markets. In 2008, the company generated sales of CHF 5.9 billion from continued operations and invested over CHF 230 million in R&D. For more information, please visit www.ciba.com.

About Sopheon

Sopheon (LSE:SPE) is an international provider of product lifecycle management software and services. Its solutions help organizations increase revenues and profits from new products by synchronizing innovation planning and execution. Sopheon's Accolade® software automates the product innovation process and provides strategic decision support for the management of product portfolios. Its Vision Strategist solution automates the roadmapping process, allowing users to visualize and forecast the future of products, markets and technologies. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Cadbury Schweppes, Corning, Electrolux, General Motors, Honeywell, Motorola, Nestle and SAB Miller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASFIFASSUSESD
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.